Agnina, hypertension and Birth Control treatment and medications.....BD
December 7, 2007 The US Food and Drug Administration (FDA) has approved first-time generic formulations for nifedipine extended-release tablets in 90-mg strength for the management of angina and treatment of hypertension; norethindrone acetate and ethinyl estradiol tablets (28-day) in 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg strengths for the prevention of pregnancy and treatment of moderate acne vulgaris in females; and norethindrone acetate and ethinyl estradiol tablets (21-day) in 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg strengths for the prevention of pregnancy and treatment of moderate acne vulgaris in females.
First-Time Generic Approvals: Procardia XL, Estrostep FE, Estrostep
0 comments :
Post a Comment